论文部分内容阅读
随着医学的不断发展,近年来发现,维生素K_1在人体内不但为凝血因子的合成原料,同时还具有平滑肌解痉、对抗组织胺作用等。现将我院1995年——1997年间住院用维生素K_1佐治的婴幼儿喘憋性肺炎60例报告如下。1.临床资料1.1 病例选择 选择病史、病程经过、临床征症相同病例120例,按随机抽样原则分成治疗组及对照组各60例。年龄及性别:对照组:0~1岁39人,男21人,女18人,1~3岁21人,男11人,女10人。治疗组,0~1岁40人,男23人,女17人,1~3岁20人,男8人,女12人。
With the continuous development of medicine, in recent years, it has been found that vitamin K_1 is not only a synthetic raw material for clotting factor in the human body, but also has smooth muscle spasm and antihistamine action. Now in our hospital from 1995 to 1997, hospitalized with vitamin K_1 adjuvant treatment of infantile asthmatic pneumonia in 60 cases are reported below. 1. Clinical data 1.1 Select the history of the case Select the course of the disease, the same clinical symptoms of 120 cases, according to the principle of random sampling divided into treatment group and control group of 60 cases. Age and sex: control group: 0 to 1 year old 39 people, 21 males and 18 females, 1 to 3 years old 21 people, 11 males and 10 females. Treatment group, 0 to 1 year old 40 people, 23 males and 17 females, 1 to 3 years old 20 people, 8 males and 12 females.